FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2145279982> ?p ?o ?g. }

• W2145279982 endingPage "876" @default.
• W2145279982 startingPage "869" @default.
• W2145279982 abstract "Diabetes and hypertension are complex and serious diseases that may ultimately lead to renal complications. Adequate control of blood glucose and blood pressure contributes to decreased renal risks, but may not be sufficient for certain patients. The current study was undertaken to investigate the renoprotective effects of berberine as an adjuvant therapy to standard hypotensive and hypoglycemic treatment in hypertensive patients with type 2 diabetes mellitus (T2DM). In this 2-year clinical study, 69 hypertensive patients with T2DM, whose blood pressure and fasting plasma glucose (FPG) were adequately controlled by hypotensive and oral hypoglycemic agents prior to the study, were enrolled and randomly assigned into control (33 cases) and add-on (36 cases) groups. Berberine was orally administrated to the patients in the add-on group concomitantly with standard hypotensive and hypoglycemic treatment. Baseline characteristics, including the levels of FPG, glycated hemoglobin, systolic blood pressure, diastolic blood pressure, serum creatinine, urinary albumin-to-creatine ratio (UACR), urinary osteopontin and kidney injury molecule-1 (KIM-1) were determined. Furthermore, the oxidative stress markers malondialdehyde, urinary 8-hydroxy-2'-deoxyguanosine, superoxide dismutase, glutathione peroxidase and total-antioxidant capacity, and the inflammatory parameters vascular adhesion molecule-1, C-reactive protein and high molecular weight-adiponectin were evaluated. In addition, ultrasonographic parameters, including peak systolic velocity, end diastolic velocity and renal arterial resistance index were determined. After treatment, it was observed that the control and add-on treatments were able to adequately control blood pressure and blood glucose. Patients in the add-on group exhibited significant reductions in renal damage biochemical markers (UACR, urinary osteopontin and KIM-1) and improved renal hemodynamics, in addition to reduced inflammation and oxidative stress. The present results suggest that berberine is beneficial for hypertensive patients with T2DM as add-on therapy to standard hypotensive and hypoglycemic agents." @default.
• W2145279982 created "2016-06-24" @default.
• W2145279982 creator A5015860750 @default.
• W2145279982 creator A5022263793 @default.
• W2145279982 creator A5024790920 @default.
• W2145279982 creator A5044939434 @default.
• W2145279982 creator A5055413532 @default.
• W2145279982 date "2015-06-22" @default.
• W2145279982 modified "2023-10-02" @default.
• W2145279982 title "Renoprotective effects of berberine as adjuvant therapy for hypertensive patients with type 2 diabetes mellitus: Evaluation via biochemical markers and color Doppler ultrasonography" @default.
• W2145279982 cites W1525885237 @default.
• W2145279982 cites W1557439438 @default.
• W2145279982 cites W1793977920 @default.
• W2145279982 cites W193430460 @default.
• W2145279982 cites W1965105866 @default.
• W2145279982 cites W1965807556 @default.
• W2145279982 cites W1966032162 @default.
• W2145279982 cites W1971254167 @default.
• W2145279982 cites W1973526632 @default.
• W2145279982 cites W1976993835 @default.
• W2145279982 cites W1987353444 @default.
• W2145279982 cites W1996296076 @default.
• W2145279982 cites W1999984504 @default.
• W2145279982 cites W2005426555 @default.
• W2145279982 cites W2010098510 @default.
• W2145279982 cites W2012022623 @default.
• W2145279982 cites W2012167039 @default.
• W2145279982 cites W2013738156 @default.
• W2145279982 cites W2016024693 @default.
• W2145279982 cites W2022328756 @default.
• W2145279982 cites W2027589607 @default.
• W2145279982 cites W2030686490 @default.
• W2145279982 cites W2033214009 @default.
• W2145279982 cites W2035905594 @default.
• W2145279982 cites W2042687731 @default.
• W2145279982 cites W2044563386 @default.
• W2145279982 cites W2050215927 @default.
• W2145279982 cites W2056056517 @default.
• W2145279982 cites W2058005418 @default.
• W2145279982 cites W2058483506 @default.
• W2145279982 cites W2060853764 @default.
• W2145279982 cites W2061759813 @default.
• W2145279982 cites W2063980080 @default.
• W2145279982 cites W2064030157 @default.
• W2145279982 cites W2071112830 @default.
• W2145279982 cites W2097980954 @default.
• W2145279982 cites W2101841456 @default.
• W2145279982 cites W2106609827 @default.
• W2145279982 cites W2107404309 @default.
• W2145279982 cites W2107409604 @default.
• W2145279982 cites W2112497605 @default.
• W2145279982 cites W2116882960 @default.
• W2145279982 cites W2119922737 @default.
• W2145279982 cites W2130709533 @default.
• W2145279982 cites W2134441749 @default.
• W2145279982 cites W2142937886 @default.
• W2145279982 cites W2164312476 @default.
• W2145279982 cites W2170508439 @default.
• W2145279982 cites W2319408249 @default.
• W2145279982 cites W2353878601 @default.
• W2145279982 cites W2408231082 @default.
• W2145279982 cites W4244182132 @default.
• W2145279982 cites W50549045 @default.
• W2145279982 doi "https://doi.org/10.3892/etm.2015.2585" @default.
• W2145279982 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4533140" @default.
• W2145279982 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26622407" @default.
• W2145279982 hasPublicationYear "2015" @default.
• W2145279982 type Work @default.
• W2145279982 sameAs 2145279982 @default.
• W2145279982 citedByCount "45" @default.
• W2145279982 countsByYear W21452799822016 @default.
• W2145279982 countsByYear W21452799822017 @default.
• W2145279982 countsByYear W21452799822018 @default.
• W2145279982 countsByYear W21452799822019 @default.
• W2145279982 countsByYear W21452799822020 @default.
• W2145279982 countsByYear W21452799822021 @default.
• W2145279982 countsByYear W21452799822022 @default.
• W2145279982 countsByYear W21452799822023 @default.
• W2145279982 crossrefType "journal-article" @default.
• W2145279982 hasAuthorship W2145279982A5015860750 @default.
• W2145279982 hasAuthorship W2145279982A5022263793 @default.
• W2145279982 hasAuthorship W2145279982A5024790920 @default.
• W2145279982 hasAuthorship W2145279982A5044939434 @default.
• W2145279982 hasAuthorship W2145279982A5055413532 @default.
• W2145279982 hasBestOaLocation W21452799821 @default.
• W2145279982 hasConcept C126322002 @default.
• W2145279982 hasConcept C126894567 @default.
• W2145279982 hasConcept C134018914 @default.
• W2145279982 hasConcept C2777180221 @default.
• W2145279982 hasConcept C2777538456 @default.
• W2145279982 hasConcept C2780306776 @default.
• W2145279982 hasConcept C555293320 @default.
• W2145279982 hasConcept C71924100 @default.
• W2145279982 hasConcept C84393581 @default.
• W2145279982 hasConcept C90924648 @default.
• W2145279982 hasConceptScore W2145279982C126322002 @default.
• W2145279982 hasConceptScore W2145279982C126894567 @default.
• W2145279982 hasConceptScore W2145279982C134018914 @default.

• next